Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Filip Y F L, de Vos"'
Autor:
Naomi C. A. van der Velden, Hanneke W. M. van Laarhoven, Sjaak A. Burgers, Lizza E. L. Hendriks, Filip Y. F. L. de Vos, Anne-Marie C. Dingemans, Joost Jansen, Jan-Maarten W. van Haarst, Joyce Dits, Ellen MA Smets, Inge Henselmans
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background For some patients with advanced cancer not knowing prognosis is essential. Yet, in an era of informed decision-making, the potential protective function of unawareness is easily overlooked. We aimed to investigate 1) the proportio
Externí odkaz:
https://doaj.org/article/6d4c5128f8fe44f6b62fc9aaba415b37
Autor:
Emma van Kessel, Ewoud Schuit, Irene M. C. Huenges Wajer, Carla Ruis, Filip Y. F. L. De Vos, Joost J. C. Verhoeff, Tatjana Seute, Martine J. E. van Zandvoort, Pierre A. Robe, Tom J. Snijders
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Background: Diffuse gliomas, which are at WHO grade II-IV, are progressive primary brain tumors with great variability in prognosis. Our aim was to investigate whether pre-operative cognitive functioning is of added value in survival prediction in th
Externí odkaz:
https://doaj.org/article/f5fe308b91034fba9bfa10e59f1b0199
Autor:
Vivek Subbiah, Robert J. Kreitman, Zev A. Wainberg, Anas Gazzah, Ulrik Lassen, Alexander Stein, Patrick Y. Wen, Sascha Dietrich, Maja J. A. de Jonge, Jean-Yves Blay, Antoine Italiano, Kan Yonemori, Daniel C. Cho, Filip Y. F. L. de Vos, Philippe Moreau, Elena Elez Fernandez, Jan H. M. Schellens, Christoph C. Zielinski, Suman Redhu, Aislyn Boran, Vanessa Q. Passos, Palanichamy Ilankumaran, Yung-Jue Bang
Publikováno v:
Nature medicine, vol 29, iss 5
Scientia
Nature Medicine, 29(5), 1103-1112. Nature Publishing Group
Scientia
Nature Medicine, 29(5), 1103-1112. Nature Publishing Group
BRAFV600E alterations are prevalent across multiple tumors. Here we present final efficacy and safety results of a phase 2 basket trial of dabrafenib (BRAF kinase inhibitor) plus trametinib (MEK inhibitor) in eight cohorts of patients with BRAFV600E-
Autor:
Naomi Cornelia Anna van der Velden, Paul K J Han, Hanneke W M van Laarhoven, Filip Y F L de Vos, Lizza E L Hendriks, Sjaak A Burgers, Anne-Marie C Dingemans, Jan Maarten W van Haarst, Joyce Dits, Ellen M A Smets, Inge Henselmans
Publikováno v:
Oncologist.
Background Discordance between physicians’ and patients’ prognostic perceptions in advanced cancer care threatens informed medical decision-making and end-of-life preparation, yet this phenomenon is poorly understood. We sought to: (1) describe t
Autor:
Nina A, Hilkens, Roelien H, Enting, Lizza E L, Hendriks, Frank J, Lagerwaard, Filip Y F L, de Vos, J M M, Gijtenbeek
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 164
The guideline on brain metastasis from the Netherlands Society of Neurology has been updated. Important changes have been made, particularly with regard to treatment of brain metastases. Treatment of patients with brain metastases is complex and requ
Autor:
Sasja F. Mulder, Iris D. Nagtegaal, Filip Y F L De Vos, Jurgen J. Fütterer, Winette T. A. van der Graaf, Joost P.H. Drenth
Publikováno v:
BMC Cancer
BMC Cancer, 13
BMC Cancer, 13
Contains fulltext : 125443.pdf (Publisher’s version ) (Open Access) BACKGROUND: Bleomycin has become an integral part of chemotherapy in patients with germ-cell tumors. One of the most feared side effects is bleomycin-induced pneumonitis. In patien
Publikováno v:
Annals of Hematology
Dear Editor, “Histiocytic sarcoma” is a rare haematological neoplasm with immunohistochemical and morphological diagnostic criteria per exclusionem. In this case report, our patient illustrates that this rare tumour with its unique location and d